The U.S. Food and Drug Administration (FDA) will hold a public advisory committee meeting of the National Mammography Quality Assurance Advisory Committee on September 15 in Gaithersburg, MD.
The agenda will include the following:
- Current compliance trends with the Mammography Quality Standards Act (MQSA)
- A proposal to use the agency's inspection program to enhance image quality
- A discussion of the quality control manual for full-field digital mammography from the American College of Radiology (ACR)
- A presentation of current issues related to breast density and cancer screening, including how these might affect a possible MQSA requirement for reporting breast density
- Future challenges for MQSA, such as the role of synthesized 2D images
Meeting attendees may present data, information, or perspectives on these agenda items either orally or in writing. Written responses must be submitted before September 7.
